奥赛康

002755 SZSE 证监会行业分类 C27医药制造业

Key Metrics

Market Cap

13.2B ($1.9B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

1.8B

Net Income

128.0M

Gross Margin

N/A

Op. Margin

8.8%

Net Margin

7.2%

ROE

4.1%

ROA

3.2%

D/E

0.29

Dividend Yield

N/A

EPS

0.17

Current Ratio

3.13

Price History

Company Info

Industry	C27医药制造业
Market Segment	SME
Currency	CNY
Fiscal Year	2024

Business Overview

Beijing Aosaikang Pharmaceutical Co., Ltd. researches, develops, manufactures, markets, and sells pharmaceuticals, fine chemicals, and health-care products in China. It offers proton pump inhibitor injections and oncology medicines, as well as APIs. The company provides its products in oncology, antibiotic, and other areas. Beijing Aosaikang Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 奥赛康

Ticker	002755
Exchange	SZSE
Sector	证监会行业分类
Industry	C27医药制造业